Navigation Links
Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
Date:8/20/2012

MOUNTAIN VIEW, Calif., Aug. 20, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company will participate in the Stifel Nicolaus 2012 Healthcare Conference, being held in Boston, MA, on September 5 - 6, 2012.  The Alexza corporate presentation will be Wednesday, September 5, 2012 at 1:30 p.m. Eastern Time.  The presentation will be webcast live.

To access the presentation via the Web, please go to the Alexza Investor Relations tab at www.alexza.com or directly at www.veracast.com/webcasts/stifel/healthcare2012/11110602.cfm.  A replay of the webcast will be available approximately 24 hours after the presentation and archived for 14 days.

About Alexza Pharmaceuticals, Inc.
Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  With the Staccato system, a drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

ADASUVE™ (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. 
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuveā„¢ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
10. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
11. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:4/17/2014)... 2014U.S. military personnel who served in Iraq and ... brain injury (TBI) were compared to military personnel ... reasons. Differences in measures of overall disability, cognitive ... injury are reported in an article in ... Mary Ann Liebert, Inc., publishers. The article is ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... School of Medicine (BUSM) have discovered that the ... experimental model. The findings, reported in the ... may lead to more effective treatments for alcoholism. ... the leading causes of illness and death in ... by limiting the productivity of workers and necessitating ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
(Date:4/17/2014)... these days to find a colored ribbon representing a disease. ... But what color ribbon does one think of with lung ... for many suffering from the disease, black may be the ... consisting of lung cancer patients, primarily smokers between the ages ... on the stigma often felt by these patients, the emotional ...
Breaking Medicine News(10 mins):Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... ... ... ... ...
... , ... , ... , , , , ... ...
... PORTLAND, Ore. Women aged 50 to 76 who take ... cancer, according to a new study published in the pre-print ... Although the risk is "duration-dependent," with women taking HRT ... an acceptable length of HRT has yet to be determined, ...
... tell which diet would work best for you, study suggests , ... to cut carbs or fats to lose weight? A DNA test ... for you, new research suggests. , Researchers from Stanford University used ... obese women were assigned to one of four popular diets for ...
... ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Centene Corporation to Present at Cowen and Company Annual Health Care Conference 2Health News:Centene Corporation to Present at Cowen and Company Annual Health Care Conference 3Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 2Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 3Health News:Hormone replacement therapy linked to increased lung cancer risk 2Health News:A Cheek Swab to Choose Your Diet Plan? 2Health News:A Cheek Swab to Choose Your Diet Plan? 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 2Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 4Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 5Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 6Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 7Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 2Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 3
... The Vasculight VS system improves the ... (sun-induced freckles), most benign brown pigments, telangiectasias, ... of Intense Pulsed Light (IPLTM) treats pigmentary ... The unique, combined approach of IPL and ...
... The new IPL Quantum DL ... technology with the reliability and simplicity ... Its modular and upgradeable design protects ... the SR mode for IPL skin ...
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
Each jet black lens features a mesmerizing thin white line that spirals toward the center of the pupil....
Medicine Products: